Filing metadata

Accession number
0001493152-24-009319
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Mar 08, 2024
Reporting period
Feb 29, 2024
Description
Insider transaction

Explore SEC Filings Hub